Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02190487
Other study ID # 3-2011-0076
Secondary ID
Status Completed
Phase N/A
First received July 11, 2014
Last updated July 14, 2014
Start date May 2011
Est. completion date January 2013

Study information

Verified date July 2014
Source Yonsei University
Contact n/a
Is FDA regulated No
Health authority Korea: Food and Drug Administration
Study type Observational

Clinical Trial Summary

Acute kidney injury (AKI) is one of the most frequently encountered and prognostically significant complications after cardiovascular surgery. However, there is no definitive treatment to intervene after development of AKI, therefore, preventive strategy has been the major issue. By this time, incidence of AKI after cardiovascular surgery has been reported 3-50% based on the studies with various definition of AKI and different patient cohorts. Development of unified definition for AKI in the early 2000s opened a new era in AKI study.

According to the previous studies, aortic surgery, especially thoracic aortic surgery was known to be highly prevalent of AKI, which was considered to be caused by use of total circulatory arrest (TCA), relatively high number of emergency cases, combined malperfusion syndrome before surgery and relatively complicated surgical procedure. However, there has not been many studies of AKI in thoracic aortic surgery because of its low incidence and urgent clinical presentation of aortic pathology, which hinder large randomized controlled study. Moreover, there are conflicting reports of incidence and risk factors of AKI after thoracic aortic surgery, no conclusive result has been made. Therefore, this study was designed to investigate the incidence and risk factors after thoracic aortic surgery only due to dissection.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date January 2013
Est. primary completion date January 2013
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- thoracic aortic surgery due to dissection

Exclusion Criteria:

- chronic kidney disease on renal replacement therapy before surgery

- death during or within 24 hours after surgery

Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Related Conditions & MeSH terms


Locations

Country Name City State
Korea, Republic of Gangnam Severance Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary incidence of acute kidney injury based of RIFLE criteria serum creatinine, GFR were retrospectively retrieved from electrical medical record upto 7days after surgery. upto 7 days after surgery No
Secondary Risk factors of acute kidney injury age, sex, comorbidities
serum creatinine, hemoglobin,mean arterial blood pressure
CPB duration, aorta cross clamping duration, total circulatory arrest duration, operative procedures performed, amount of transfused blood components
serum creatinine upto 7 days after surgery, mean arterial pressure, cardiac index, amount of transfused blood components in intensive care unit, ventiltor duration, ICU stay duration, renal replacement therapy, 30-day mortality
after diagnosis of acute kidney injury after operation (usually within 7 days after operation) No
See also
  Status Clinical Trial Phase
Recruiting NCT05639569 - Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study
Completed NCT01369732 - Prevention of Acute Kidney Injury by Erythropoietin in Thoracic Aorta Surgery With Hypothermic Cardiac Arrest Phase 4
Active, not recruiting NCT05030740 - French Assessment of the Relay Plus and Relay NBS Plus Thoracic Stent-Graft
Recruiting NCT03322033 - Feasibility of Endovascular Repair of Ascending Aortic Pathologies N/A